The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC
Guti, Eliza, Regdon, Zsolt, Sturniolo, Isotta, Kiss, Alexandra, Kovács, Katalin, Demény, Máté, Szöőr, Árpád, Vereb, György, Szöllősi, János, Hegedűs, Csaba, Polgár, Zsuzsanna, Virág, László
Published in Cancer Immunology, Immunotherapy (01.09.2022)
Published in Cancer Immunology, Immunotherapy (01.09.2022)
Get full text
Journal Article